Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)

Completed

Phase 2 Results

Summary of Purpose

To determine whether the extent of the ischemic penumbra apparent on perfusion-diffusion MRI can be used to identify patients who would respond positively and safely to tissue plasminogen activator (tPA) beyond 3 hours post-stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 May 2013.

1 Aug 2001 11 Oct 2005 Unavailable 1 Apr 2007 1 May 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available